Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3769529012 | Product containing precisely Varicella-zoster virus antibody 250 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| 3769530019 | Varicella-zoster virus antibody 250 mg powder for solution for injection vial | en | Synonym | Active | Case sensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has BoSS | Varicella-zoster virus antibody | true | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has precise active ingredient | Varicella-zoster virus antibody | true | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has presentation strength numerator value | 250 | false | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 | |
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Is a | Varicella-zoster virus antibody only product in parenteral dose form | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Plays role | Passive immunity stimulant therapeutic role | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Is a | Varicella-zoster virus antibody-containing product | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has active ingredient | Antiserum | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has active ingredient | Immunoglobulin | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has active ingredient | Varicella-zoster virus antibody | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Has manufactured dose form | Powder for solution for injection | true | Inferred relationship | Some | ||
| Varicella-zoster virus antibody 250 mg powder for solution for injection vial | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR